HemaSphere (Jun 2022)

S188: TECLISTAMAB IN COMBINATION WITH DARATUMUMAB, A NOVEL, IMMUNOTHERAPY-BASED APPROACH FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS

  • P. Rodriguez Otero,
  • A. D’Souza,
  • D. Reece,
  • N. W. van de Donk,
  • A. Chari,
  • A. Krishnan,
  • T. Martin,
  • M. V. Mateos,
  • D. Morillo,
  • D. Hurd,
  • L. Rosinol,
  • A. S. Balari,
  • R. Wäsch,
  • D. Vishwamitra,
  • S. X. Wang Lin,
  • T. Prior,
  • L. Vandenberk,
  • M.-A. D. Smit,
  • A. Oriol,
  • B. Dholaria

DOI
https://doi.org/10.1097/01.HS9.0000843644.02496.66
Journal volume & issue
Vol. 6
pp. 89 – 90

Abstract

Read online

No abstracts available.